cardiovascular health

Tirzepatide is the first-in-class dual GIP and GLP-1 receptor agonist, delivering unprecedented results in weight loss and

A clear-eyed look at how semaglutide works, what the research actually shows, and what to weigh before considering it, presented

A deep dive into the science, clinical trial data, and real-world implications of the most powerful weight-loss peptide ever